Abstract
In recent years, there has been an increase in the study of metabolic illnesses and the gut microbiota. According to certain research, the pathogenesis and development of various metabolic illnesses, including type 1 and type 2 diabetes and obesity, may be significantly influenced by bacterial microbiome dysbiosis, and additionally, it has affected brain functions through metabolism. Recently, human research has discovered specific microbiota that are favorable and unfavorable to brain function. For instance, the Firmicutes phylum, which includes Clostridium, Ruminococcus, and Eubacterium, was beneficial to cognition, whereas the Bacteroidetes and Proteobacteria were detrimental. These results might encourage more investigation into the connections between the gut and cognition and mental health as well as to study the mechanisms of these relationships. With a focus on the gut microbiota and its relationships with physiological systems, the novel results that have so far been made show promise for identifying new therapeutic targets through food and nutrition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abner EL, Nelson PT, Kryscio RJ, Schmitt FA, Fardo DW, Woltjer RL, Cairns NJ, Yu L, Dodge HH, Xiong C, Masaki K, Tyas SL, Bennett DA, Schneider JA, Arvanitakis Z. Diabetes is associated with cerebrovascular but not Alzheimer’s disease neuropathology. Alzheimers Dement. 2016;12(8):882. https://doi.org/10.1016/j.jalz.2015.12.006.
Anderson JR, Carroll I, Azcarate-Peril MA, Rochette AD, Heinberg LJ, Peat C, Steffen K, Manderino LM, Mitchell J, Gunstad J. A preliminary examination of gut microbiota, sleep, and cognitive flexibility in healthy older adults. Sleep Med. 2017;38:104–7. https://doi.org/10.1016/j.sleep.2017.07.018.
Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, Craft S, Gandy S, Buettner C, Stoeckel LE, Holtzman DM, Nathan DM. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol. 2018;14(3):168. https://doi.org/10.1038/nrneurol.2017.185.
Arnoriaga-Rodríguez M, Mayneris-Perxachs J, Burokas A, Contreras-Rodríguez O, Blasco G, Coll C, Biarnés C, Miranda-Olivos R, Latorre J, Moreno-Navarrete JM, Castells-Nobau A, Sabater M, Palomo-Buitrago ME, Puig J, Pedraza S, Gich J, Pérez-Brocal V, Ricart W, Moya A, … Fernández-Real JM. Obesity impairs short-term and working memory through gut microbial metabolism of aromatic amino acids. Cell Metab. 2020;32(4). https://doi.org/10.1016/j.cmet.2020.09.002.
Arnoriaga-Rodríguez M, Mayneris-Perxachs J, Contreras-Rodríguez O, Burokas A, Ortega-Sanchez JA, Blasco G, Coll C, Biarnés C, Castells-Nobau A, Puig J, Garre-Olmo J, Ramos R, Pedraza S, Brugada R, Vilanova JC, Serena J, Barretina J, Gich J, Pérez-Brocal V, … Fernández-Real JM. Obesity-associated deficits in inhibitory control are phenocopied to mice through gut microbiota changes in one-carbon and aromatic amino acids metabolic pathways. Gut. 2021;70(12):2283. https://doi.org/10.1136/gutjnl-2020-323371.
Banks WA, Coon AB, Robinson SM, Moinuddin A, Shultz JM, Nakaoke R, Morley JE. Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes. 2004;53(5):1253. https://doi.org/10.2337/diabetes.53.5.1253.
Blaut M. Ecology and physiology of the intestinal tract. Curr Top Microbiol Immunol. 2013;358:247. https://doi.org/10.1007/82_2011_192.
Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288-298. https://doi.org/10.1038/s41574-019-0176-8
Brands AMA, Biessels GJ, De Haan EHF, Kappelle LJ, Kessels RPC. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care. 2005;28(3):726. https://doi.org/10.2337/diacare.28.3.726.
Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28(2):203.
Caspani G, Kennedy S, Foster JA, Swann J. Gut microbial metabolites in depression: understanding the biochemical mechanisms. Microbial Cell (Graz, Austria). 2019;6(10):454–81. https://doi.org/10.15698/mic2019.10.693.
Chen Y-H, Bai J, Wu D, Yu S-F, Qiang X-L, Bai H, Wang H-N, Peng Z-W. Association between fecal microbiota and generalized anxiety disorder: severity and early treatment response. J Affect Disord. 2019;259:56–66. https://doi.org/10.1016/j.jad.2019.08.014.
Chen Y, Xu J, Chen Y. Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders. Nutrients. 2021;13(6):2099. https://doi.org/10.3390/nu13062099.
Cussotto S, Delgado I, Anesi A, Dexpert S, Aubert A, Beau C, Forestier D, Ledaguenel P, Magne E, Mattivi F, Capuron L. Tryptophan metabolic pathways are altered in obesity and are associated with systemic inflammation. Front Immunol. 2020;11:557. https://doi.org/10.3389/fimmu.2020.00557.
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. Washington, DC, American Psychiatric Association, 2022
Durgan DJ, Lee J, McCullough LD, Bryan RM. Examining the role of the microbiota-gut-brain axis in stroke. Stroke. 2019;50(8):2270. https://doi.org/10.1161/STROKEAHA.119.025140.
Farr SA, Banks WA, Morley JE. Effects of leptin on memory processing. Peptides. 2006;27(6):1420. https://doi.org/10.1016/j.peptides.2005.10.006.
Fernandez-Real JM, Serino M, Blasco G, Puig J, Daunis-I-Estadella J, Ricart W, Burcelin R, Fernández-Aranda F, Portero-Otin M. Gut microbiota interacts with brain microstructure and function. J Clin Endocrinol Metab. 2015;100(12):4505. https://doi.org/10.1210/jc.2015-3076.
Freeman CR, Zehra A, Ramirez V, Wiers CE, Volkow ND, Wang GJ. Impact of sugar on the body, brain, and behavior. Front Biosci Landmark. 2018;23(12):2255. https://doi.org/10.2741/4704.
Hartanto A, Yong JC, Toh WX. Bidirectional associations between obesity and cognitive function in midlife adults: a longitudinal study. Nutrients. 2019;11(10):2343. https://doi.org/10.3390/nu11102343.
Herrmann MJ, Tesar AK, Beier J, Berg M, Warrings B. Grey matter alterations in obesity: a meta-analysis of whole-brain studies. Obes Rev. 2019;20(3):464. https://doi.org/10.1111/obr.12799.
Hughes TM, Ryan CM, Aizenstein HJ, Nunley K, Gianaros PJ, Miller R, Costacou T, Strotmeyer ES, Orchard TJ, Rosano C. Frontal gray matter atrophy in middle aged adults with type 1 diabetes is independent of cardiovascular risk factors and diabetes complications. J Diabetes Complicat. 2013;27(6):558. https://doi.org/10.1016/j.jdiacomp.2013.07.001.
Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D’Agostino RB, DeCarli C. Stroke risk profile predicts white matter hyperintensity volume: the Framingham study. Stroke. 2004;35(8):1857. https://doi.org/10.1161/01.STR.0000135226.53499.85.
John GK, Mullin GE. The gut microbiome and obesity. Curr Oncol Rep. 2016;18(7):45. https://doi.org/10.1007/s11912-016-0528-7.
Keen EC, Dantas G. Close encounters of three kinds: bacteriophages, commensal bacteria, and host immunity. Trends Microbiol. 2018;26(11):943. https://doi.org/10.1016/j.tim.2018.05.009.
Liu L, Zhang J, Cheng Y, Zhu M, Xiao Z, Ruan G, Wei Y. Gut microbiota: a new target for T2DM prevention and treatment. Front Endocrinol. 2022;13:958218. https://doi.org/10.3389/fendo.2022.958218.
Loprinzi PD, Frith E. Obesity and episodic memory function. J Physiol Sci. 2018;68(4):321. https://doi.org/10.1007/s12576-018-0612-x.
Mayer EA, Nance K, Chen S. The gut-brain axis. Annu Rev Med. 2022;73:439–53. https://doi.org/10.1146/annurev-med-042320-014032.
Mayneris-Perxachs J, Castells-Nobau A, Arnoriaga-Rodríguez M, Garre-Olmo J, Puig J, Ramos R, Martínez-Hernández F, Burokas A, Coll C, Moreno-Navarrete JM, Zapata-Tona C, Pedraza S, Pérez-Brocal V, Ramió-Torrentà L, Ricart W, Moya A, Martínez-García M, Maldonado R, Fernández-Real JM. Caudovirales bacteriophages are associated with improved executive function and memory in flies, mice, and humans. Cell Host Microbe. 2022a;30(3):340. https://doi.org/10.1016/j.chom.2022.01.013.
Mayneris-Perxachs J, Castells-Nobau A, Arnoriaga-Rodríguez M, Martin M, de la Vega-Correa L, Zapata C, Burokas A, Blasco G, Coll C, Escrichs A, Biarnés C, Moreno-Navarrete JM, Puig J, Garre-Olmo J, Ramos R, Pedraza S, Brugada R, Vilanova JC, Serena J, … Fernández-Real JM. Microbiota alterations in proline metabolism impact depression. Cell Metab. 2022b;34(5):681–701.e10. https://doi.org/10.1016/j.cmet.2022.04.001.
Moheet A, Mangia S, Seaquist ER. Impact of diabetes on cognitive function and brain structure. Ann N Y Acad Sci. 2015;1353(1):60. https://doi.org/10.1111/nyas.12807.
Mokhtari P, Metos J, Anandh Babu PV. Impact of type 1 diabetes on the composition and functional potential of gut microbiome in children and adolescents: possible mechanisms, current knowledge, and challenges. Gut Microbes. 2021;13(1):1–18. https://doi.org/10.1080/19490976.2021.1926841.
Moran C, Phan TG, Chen J, Blizzard L, Beare R, Venn A, Münch G, Wood AG, Forbes J, Greenaway TM, Pearson S, Srikanth V. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care. 2013;36(12):4036. https://doi.org/10.2337/dc13-0143.
Murphy J, Mahony J, Fitzgerald GF, van Sinderen D. Bacteriophages infecting lactic acid bacteria. Cheese. 2017;1:249–72. https://doi.org/10.1016/B978-0-12-417012-4.00010-7.
Musen G, In KL, Sparks CR, Weinger K, Hwang J, Ryan CM, Jimerson DC, Hennen J, Renshaw PF, Jacobson AM. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes. 2006;55(2):326. https://doi.org/10.2337/diabetes.55.02.06.db05-0520.
Naveed M, Zhou QG, Xu C, Taleb A, Meng F, Ahmed B, Zhang Y, Fukunaga K, Han F. Gut-brain axis: a matter of concern in neuropsychiatric disorders…! Prog Neuro-Psychopharmacol Biol Psychiatry. 2021;104:110051. https://doi.org/10.1016/j.pnpbp.2020.110051.
Oei NYL, Elzinga BM, Wolf OT, de Ruiter MB, Damoiseaux JS, Kuijer JPA, Veltman DJ, Scheltens P, Rombouts SARB. Glucocorticoids decrease hippocampal and prefrontal activation during declarative memory retrieval in young men. Brain Imaging Behav. 2007;1(1–2):31. https://doi.org/10.1007/s11682-007-9003-2.
Papageorgiou I, Astrakas LG, Xydis V, Alexiou GA, Bargiotas P, Tzarouchi L, Zikou AK, Kiortsis DN, Argyropoulou MI. Abnormalities of brain neural circuits related to obesity: a Diffusion Tensor Imaging study. Magn Reson Imaging. 2017;37:116. https://doi.org/10.1016/j.mri.2016.11.018.
Peixoto LL, Wimmer ME, Poplawski SG, Tudor JC, Kenworthy CA, Liu S, Mizuno K, Garcia BA, Zhang NR, Giese KP, Abel T. Memory acquisition and retrieval impact different epigenetic processes that regulate gene expression. BMC Genomics. 2015;16(5):S5. https://doi.org/10.1186/1471-2164-16-S5-S5.
Prince Martin. World Alzheimer Report. Published online 2015. https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf
Scheithauer TPM, Dallinga-Thie GM, de Vos WM, Nieuwdorp M, van Raalte DH. Causality of small and large intestinal microbiota in weight regulation and insulin resistance. Mol Metab. 2016;5(9):759. https://doi.org/10.1016/j.molmet.2016.06.002.
Schulfer A, Santiago-Rodriguez TM, Ly M, Borin JM, Chopyk J, Blaser MJ, Pride DT. Fecal viral community responses to high-fat diet in mice. MSphere. 2020;5(1):e00833. https://doi.org/10.1128/msphere.00833-19.
Strandwitz P, Kim KH, Terekhova D, Liu JK, Sharma A, Levering J, McDonald D, Dietrich D, Ramadhar TR, Lekbua A, Mroue N, Liston C, Stewart EJ, Dubin MJ, Zengler K, Knight R, Gilbert JA, Clardy J, Lewis K. GABA-modulating bacteria of the human gut microbiota. Nat Microbiol. 2019;4(3):396. https://doi.org/10.1038/s41564-018-0307-3.
Syan SK, Owens MM, Goodman B, Epstein LH, Meyre D, Sweet LH, MacKillop J. Deficits in executive function and suppression of default mode network in obesity. NeuroImage: Clinical. 2019;24:102015. https://doi.org/10.1016/j.nicl.2019.102015.
Tilg H, Zmora N, Adolph TE, Elinav E. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol. 2020;20(1):40. https://doi.org/10.1038/s41577-019-0198-4.
Val-Laillet D, Aarts E, Weber B, Ferrari M, Quaresima V, Stoeckel LE, Alonso-Alonso M, Audette M, Malbert CH, Stice E. Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity. NeuroImage: Clinical. 2015;8:1. https://doi.org/10.1016/j.nicl.2015.03.016.
Van Den Berg E, Reijmer YD, De Bresser J, Kessels RPC, Kappelle LJ, Biessels GJ. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia. 2010;53(1):58. https://doi.org/10.1007/s00125-009-1571-9.
World Health Organization. 2019. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
Zhu H, Wang N, Yao L, Chen Q, Zhang R, Qian J, Hou Y, Guo W, Fan S, Liu S, Zhao Q, Du F, Zuo X, Guo Y, Xu Y, Li J, Xue T, Zhong K, Song X, … Xiong W. Moderate UV exposure enhances learning and memory by promoting a novel glutamate biosynthetic pathway in the brain. Cell. 2018;173(7):1716. https://doi.org/10.1016/j.cell.2018.04.014.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Glossary
Glossary
- AAA:
-
Aromatic Amino Acids
- AAC:
-
Anterior Cingulate Cortex
- ADHD:
-
Attention-Deficit Hyperactivity Disorder
- BBB:
-
Blood–Brain Barrier
- BA:
-
Bile Acids
- BMI:
-
Body Mass Index
- CNS:
-
Central Nervous System
- CRISPR:
-
Clustered Regularly Interspaced Short Palindromic Repeats
- DA:
-
Dopamine
- DLPFC:
-
Dorsomedial Prefrontal Cortex
- DSM-V:
-
Diagnostic and Statistical Manual of Mental Disorders
- dTMP:
-
deoxythymidine monophosphate
- FTCD:
-
formimidoyltransferase cyclodeaminase
- GABA:
-
Gamma-aminobutyric acid
- GBA:
-
Gut–Brain Axis
- GCS:
-
Glycine Cleavage System
- GIT:
-
Gut intestinal tract
- GLP-1:
-
Glucagon-like peptide-1
- IEGs:
-
Immediate early genes
- KEGG:
-
Kyoto Encyclopedia of Genes and Genomes pathway
- LPS:
-
Lipopolysaccharides
- MHO:
-
Metabolic health obesity
- MRI:
-
Magnetic Resonance Image
- NMDA receptor:
-
N-metil-d-aspartate receptor
- OFC:
-
Orbitofrontal Cortex
- PNS:
-
Peripheral Neurological System
- PET:
-
Positron Emission Tomography
- PFC:
-
Prefrontal cortex
- T1DM:
-
Type 1 Diabetes Mellitus
- T2DM:
-
Type 2 Diabetes Mellitus
- THF:
-
Tetrahydrofolate
- TYMS:
-
Thymidylate synthase
- SAM:
-
S-adenosylmethionine
- SCFAs:
-
Short-Chain Fatty Acids
- ssDNA:
-
Single-stranded DNA
- 1C:
-
1 Carbon
Genes and Proteins
Microbial
- ABC.VB1X. P:
-
putative thiamine transport system permease protein gene
- aphA:
-
acid phosphatase/phosphotransferase
- btuB:
-
cobalamin outer membrane transporter
- folM:
-
dihydromonapterin reductase
- folX:
-
dihydroneopterin triphosphate 2′-epimerase
- fre:
-
NAD (P) H-flavin reductase
- gcvH:
-
glycine cleavage system H
- gcvP:
-
glycine decarboxylase
- gcvR:
-
GCS transcriptional repressor
- nudB:
-
dihydroneopterin triphosphate diphosphatase
- opuD:
-
glycine betaine transporter OpuD
- pabB:
-
aminodeoxychorismate synthase subunit 1
- pabC:
-
aminodeoxychorismate lyase
- pdxA:
-
4-hydroxythreonine-4-phosphate dehydrogenase
- proV:
-
glycine betaine/l-proline ABC transporter ATP
- proW:
-
betaine/proline transport system permease protein
- proX:
-
betaine/proline transport system
- purH:
-
bifunctional AICAR transformylase/IMP cyclohydrolase
- purT:
-
phosphoribosylglycinamide formyl transferase 2
- purU:
-
formyltetrahydrofolate deformylase
- queE:
-
putative 7-carboxy-7-deazaguanine synthase
- ribBA:
-
bifunctional 3,4-dihydroxy-2-butanone-4-phosphate synthase/GTP cyclohydrolase II
- SadA:
-
staphylococcal aromatic amino acid decarboxylase enzyme
- serA:
-
phosphoglycerate dehydrogenase
- serB:
-
phosphoserine phosphatase
- sox:
-
Sarcosine oxidase
- ThiB:
-
Thiamine-binding periplasmic protein
- thyX:
-
thymidylate synthase
- ubiB:
-
ubiquinone biosynthesis protein UbiB
Human
- TPH1:
-
tryptophan hydroxylase 1 gene
- TYMS:
-
Thymidylate synthase gene
Mice
- Arc:
-
Activity-regulated cytoskeleton-associated protein gene
- Fos:
-
c-Fos protein gene
- Egr2:
-
E3 SUMO-protein ligase EGR2 protein gene
- Btg2:
-
Protein BTG2 protein gene
- Ppp1r42:
-
protein phosphatase 1 regulatory subunit 42 gene
- Sik1:
-
Serine/threonine-protein kinase SIK1
- Dusp1:
-
Dual specificity protein phosphatase 1 gene
- Ier2:
-
Immediate early response gene 2 protein gene
Rights and permissions
Copyright information
© 2024 Springer Nature Switzerland AG
About this entry
Cite this entry
Motger-Albertí, A., Fernández-Real, J.M. (2024). Gut Microbiome and Cognitive Functions in Metabolic Diseases. In: Federici, M., Menghini, R. (eds) Gut Microbiome, Microbial Metabolites and Cardiometabolic Risk. Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-031-35064-1_12
Download citation
DOI: https://doi.org/10.1007/978-3-031-35064-1_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-35063-4
Online ISBN: 978-3-031-35064-1
eBook Packages: MedicineReference Module Medicine